News Center
Apr，2020
- Categories:History
- Author:
- Origin:
- Time of issue:2022-05-13 16:09
- Views:
Apr，2020
- Categories:History
- Author:
- Origin:
- Time of issue:2022-05-13 16:09
- Views:
Information
Mar InxMed Nanjing Co., Ltd founded
Mar First patient enrolled in the US
Apr Investigational New Drug (IND) application approved for IN10018 combined with chemotherapy for the treatment of high-grade serous ovarian cancer
Jul First patient enrolled in China
Sep 130 million RMB of A+ round raised to accelerate clinical development and pipeline deployment
We invent personalized medicines with global impact, and turn innovation in China to life saving therapies for the world
QUICK LINKS
CONTACT US
Tel: +86 25-58251030
Email: office@inxmed.com
Office address: 73 Tanmi Road Block D-2, 3rd Floor Jiangbei New District, Nanjing
MESSAGE
Follow Us：
CopyRight © 2022 InxMed All Rights Reserved.